Hotta, Katsuyuki <br/><br/>
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Jan 2013 
 - 20-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2012.10.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Disease-Free Survival<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Molecular Targeted Therapy<br/>Neoplasm Staging<br/>Randomized Controlled Trials as Topic